Home to Europe’s largest pharma market, a host of industry giants, a thriving biotech scene, and a public healthcare system undergoing significant reform, Germany is indisputably one of the world’s most important life science nations.
An overview of the pharma industry in Germany.
The sales revenues generated by both the prescription and over-the-counter (OTC) segments of the German pharma market in 2020.
New registrations of biopharmaceuticals (originator biologics and biosimilars) in Germany between 2016 and 2020.
Germany R&D Snapshot